(S)-cEt / Nucleoside Intermediates
DMT-protected (S)-cEt-5-Me-U free-hydroxyl precursor
Quick view. A DMT-protected (S)-cEt 5-methyluridine precursor with a free hydroxyl group, identified by CAS 1197033-21-8. CAS 1197033-21-8. Catalog target purity: Specification by inquiry. Availability: Inquiry only — contact OROGO to confirm current availability.
Request a quote Review request checklist
Catalog status
Scope. "Available for inquiry" is not a stock claim. Operating tier is a catalog-merchandising priority. Development phase and program context are shown only where the reviewed catalog source provides a mapping; they describe the chemistry platform and do not claim that OROGO supplies the named program.
| Supply status | Available for inquiry |
|---|---|
| Operating tier | Priority |
| Reviewed supporting program count | 2 |
| Representative chemistry-platform program | opemalirsen |
| Highest development phase | Phase II |
| CAS status | Published registry number |
Product profile
DMT-protected (S)-cEt-5-Me-U free-hydroxyl precursor is classified as (s)-cet / nucleoside intermediates (Formula C33H34N2O8; molecular weight 586.60).
DMT-protected (S)-cEt-5-Me-U free-hydroxyl precursor is associated with uridine-containing substrates for U-position incorporation in RNA or modified RNA studies.
For DMT-protected (S)-cEt-5-Me-U free-hydroxyl precursor, confirm the current specification, storage conditions and downstream-method compatibility before routine use.
Names and search terms
Confirmed or normalized name variants
- 1-[(1R,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methylpyrimidine-2,4-dione
Useful catalog search terms
- 1197033-21-8
- XCYNXNBWEYZWQQ-JTNNVKOGSA-N
Physicochemical data
| IUPAC name | 1-[(1R,3R,4R,6S,7S)-1-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-7-hydroxy-6-methyl-2,5-dioxabicyclo[2.2.1]heptan-3-yl]-5-methylpyrimidine-2,4-dione |
|---|---|
| InChIKey | XCYNXNBWEYZWQQ-JTNNVKOGSA-N |
| SMILES | C[C@H]1[C@]2([C@H]([C@@H](O1)[C@@H](O2)N3C=C(C(=O)NC3=O)C)O)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC |
| PubChem CID | 45139475 |
| InChI | InChI=1S/C33H34N2O8/c1-20-18-35(31(38)34-29(20)37)30-27-28(36)32(43-30,21(2)42-27)19-41-33(22-8-6-5-7-9-22,23-10-14-25(39-3)15-11-23)24-12-16-26(40-4)17-13-24/h5-18,21,27-28,30,36H,19H2,1-4H3,(H,34,37,38)/t21-,27+,28-,30+,32-/m0/s1 |
Release documentation
The current specification defines the analytical method and acceptance criteria; the released lot result is reported on the CoA.
Additional HPLC, MS or NMR documentation can be agreed during technical review where available.
Related products
DMT-protected (S)-cEt-A free-hydroxyl precursor
Intermediates · CAS: 1197033-18-3
OR-INTE-0113DMT-protected (S)-cEt-5-Me-C free-hydroxyl precursor
Intermediates · CAS: 1197033-15-0
OR-INTE-0115DMT-protected (S)-cEt-G free-hydroxyl precursor
Intermediates · CAS: 945628-65-9
OR-LP-0041Maleimide NHS Ester (SMCC)
Intermediates · CAS: 64987-85-5
OR-LP-00633'-Cholesteryl-TEG CPG
Intermediates · CAS: N/A
OR-INTE-01097'-OH-O6-[2-(4-Nitrophenyl)ethyl]-N2-isobutyryl-N-trityl morpholino guanosine
Intermediates · CAS: N/A
Product-relevant literature
The publications below discuss named chemistry or a structural feature represented by this product. They provide scientific context only and are not an OROGO lot specification or product-performance claim.